Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-15

FDA Approved: NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)

View source ↗

Summary

FDA approves norepinephrine bitartrate in sodium chloride for injection under an original application by WG Critical Care, LLC, a vasopressor used for acute man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate in sodium chloride (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE)